Holoxan is a chemotherapy drug used to treat various types of cancer, such as testicular cancer, ovarian cancer, and bone cancer. It contains ifosfamide, which destroys cancer cells by affecting their genetic material and preventing the cell from dividing and multiplying. This drug is given intravenously under medical supervision. The patient requires close monitoring during treatment because
Holoxan may cause a decrease in blood cells, bladder problems, and kidney disorders. It is also important to drink adequate amounts of water and use bladder protectors to reduce the risk of irritation. It is recommended to conduct regular blood tests to assess the body's response and adjust the dose if necessary. This drug should be avoided during pregnancy or breastfeeding, and the doctor should be informed of any other medications being used to avoid interactions.